Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2025-12-24 @ 10:44 PM
NCT ID:
NCT07250035
Eligibility Criteria:
Inclusion Criteria:
* ① Possible or very likely CAA-ICH;
* Within 7 days of onset; ③ Primary supratentorial intracerebral hemorrhage (bleeding volume ≤30ml);
* GCS≥8 points;
* NIHSS score ≤25 points; ⑥50≤age≤90 years old; ⑦ Gender is not limited; ⑧ The subject or their legal representative gives informed consent and signs the informed consent form.
Exclusion Criteria:
* Those who are known to be allergic to the components of the traditional Chinese medicine compound used in the experiment;
* It is known that after treatment with vascular malformations, aneurysms, coagulation disorders, anticoagulant or antiplatelet drugs, Intracranial conditions caused by clear etiologies such as thrombolytic therapy, post-infarction hemorrhage transformation, hematological diseases, moyamoya disease, etc;
* Patients with traumatic intracranial hemorrhage;
* Patients with active peptic ulcers or other clear tendencies of rebleeding;
* Patients with severe liver or kidney dysfunction (Note: Severe liver dysfunction is defined as ALT or AST being greater than.
⑥ Those who have received or are planning to undergo surgical treatment;
⑦ Those who suffer from other life-threatening serious diseases and have an expected survival time of less than six months;
⑧ Other conditions that significantly limit the evaluation of neurological function, prevent the completion of cranial magnetic resonance imaging, or affect the follow-up of patient;
⑨ Pregnant women, those planning to become pregnant or lactating women;
⑩Those who are currently participating in other interventional clinical trials.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
90 Years
Study:
NCT07250035
Study Brief:
Protocol Section:
NCT07250035